2026 bayer’s guide · Ɔtpidik spɔlayt kwalifayeshɔn
Fɔ pik ɔtpidik saplay na kwaliti ɛn kɔntinyuiti disizhɔn—nɔto jɔs fɔ kɔmpia prayz. Insay 2026, di wan dɛn we de bay fɔ ebul fɔ evaluate di kɔrɛnt rigyuletɔri rɛdi, prodak-lɛvel dɔkyumentri, traceability, manufakchurin kɔntrol, delivri ɛvidɛns, injinɛri sɔpɔt, ɛn post-maket rispɔns. Dis gayd de chenj dɛn tin dɛn de we dɛn nid to sɛvin krayteria, 100 poɛnt spɔlayt skɔ kad.
Aw Yu Fɔ Evaluate Ɔtpidik Saplay dɛn insay 2026?
Yuz wan risk-based prɔses wit 4 layers: prɛkwalifayshɔn, dɔkyumɛnt verifyeshɔn, sampul ɔ payɔt validɛshɔn, ɛn kɔntinyu fɔ monitar pefɔmɛns. Skɔ sɛvin eria, bɔt trit ligal aydentiti, prodak ɔtorizeshɔn, kwaliti-sistim kɔvarej, traysibiliti, ɛn krichɔ dɔkyumentri as pas/fail get.
Di bɛst shɔt ansa: pik di saplay we go ebul fɔ gi di strɔng pruf we dɛn dɔn chɛk fɔ di rayt prɔdak, di say we dɛn mek am, di say we dɛn de go, ɛn di saplay-chen rol—nɔto di saplay we gɛt di katalog we lɔng pas ɔl ɔ di fɔs kot we smɔl pas ɔl.
Wetin Chenj pan Mɛdikal Divays Saplay Evalueshɔn insay 2026?
Di ia we de na di taytul fɔ kɔrɛkt to rial chenj dɛn we di lɔ dɛn dɔn mek. Tu divɛlɔpmɛnt dɛn rili afɛkt di wan dɛn we de mek ɔtpidik, di wan dɛn we de import, di wan dɛn we de sheb, ɛn di wan dɛn we gɛt di brand insay 2026.
FDA Kwaliti Manejmɛnt Sistɛm Rɛgyuleshɔn
Di FDA in Kwaliti Manejmɛnt Sistɛm Rɛgyuleshɔn bin bi ifɛktiv ɛn i inkɔrpɔret ISO 13485:2016 bay rɛfrɛns, togɛda wit US-spɛsifi k rikwaymɛnt dɛn. Di FDA bigin fɔ yuz wan ɔpdet mɛdikal-divays inspekshɔn prɔses bak. US-maket kwalifayeshɔn fɔ so ɛgzamin QMSR implimɛnt, nɔto jɔs di ɛgzistens fɔ wan ISO sɛtifiket.
Fɔs Fo EUDAMED Mɔdyul dɛn
Di fɔs 4 EUDAMED modul dɛn bin bi mandatory: Aktɔ Rɛjista, UDI/Divays Rɛjista, Notis Bɔdi & Sɛtifiket, ɛn Maket Sɔvɛlayshɔn. Di rivyu dɛn we de pe atɛnshɔn pan di EU fɔ inklud SRN, divays ɛn UDI data, sɛtifiket alaynɛshɔn, ɛn di rispɔnsibiliti dɛn fɔ ɛni ikɔmik ɔpreshɔn.
Impɔtant difrɛns: ISO 13485 sɛtifikeshɔn de sɔpɔt kwaliti-sistim ɛvalueshɔn, bɔt i nɔ de alaw ɛvri prɔdak we de na katalog. FDA establishmɛnt rɛjista nɔ min FDA aprɔval, kliarens, ɔ ɔtorizeshɔn. CE dɔkyumentri fɔ mach bak to di ɛksaktɔl divays, ligal manifakta, klasification, intended purpose, ɛn aplikebul kɔnfɔmiti rod.
Aw fɔ Yuz Dis Ɔtpidik Saplay Evalueshɔn Framwɔk
Bifo yu kɔntakt di saplay dɛn, difayn di prɔdak famili, di we aw dɛn want fɔ yuz am, di say we dɛn want fɔ yuz am, di say we dɛn want fɔ go, di divays klasification, di steril ɔ nɔ-steril stetɔs, di volyum fɔkɔs, di inschrumɛnt dɛn we dɛn nid, di prayvet-lɛbul skɔp, ɛn di rispɔnsibiliti dɛn fɔ di dɔkyumentri. Dɛn nɔ go ebul fɔ evalyu wan saplay fayn fayn wan agens wan rikwaymɛnt we dɛn nɔ difayn.
1Kwaliti Sistem, Rigyuletɔri Status, ɛn Ɔdit Rɛdi
Start bay we yu no di ligal manifakta ɛn ɛni sayt we de du impɔtant wok dɛn. Ditarmin udat de kɔntrol dizayn, mashin, finish, klin, pak, sterilayz, lɛbl, rilis, kɔmplen handle, ɛn rigyuletɔri sɔbmishɔn.
Rikwest di ISO 13485 sɛtifiket we de naw ɛn chɛk di ɔganayzeshɔn in nem, adrɛs, skɔp, di bɔdi we de gi di sɛtifiket, akrediteshɔn, di sɛtifiket stetɔs, ɛn di tɛm we i dɔn. Fɔ US sapɔt, aks aw di manifakta implimɛnt QMSR rikwaymɛnt dɛn. Fɔ EU saplai, kɔnfɔm di aplikebul MDR stetɔs ɛn ikɔmik-ɔpreshɔn rol dɛn.
XC Medico de pablish wan ɔvaviu fɔ in ɔtpidik kwaliti kɔntrol ɛn inspekshɔn prɔses ; di wan dɛn we de bay fɔ stil aks fɔ di prɔdak- ɛn sayt-spɛsifi k rɛkɔd dɛn we dɛn de kwalifay.
2Rɛjista-Rɛdi Prodak Dokumɛnt
Bɔku tɛm, di we aw di distribyushɔn kin delay fɔ rɛjista bikɔs di dɔkyumɛnt dɛn nɔ kɔmplit, we nɔ kin gri, ɔ we dɛn nɔ kin kɔntrol pas di kapasiti we dɛn kin mek. Evaluate wan ripɔt prodak famili instead fɔ aksept prɔmis se dɛn kin mek dɔkyumɛnt dɛn leta.
- divays diskripshɔn, di tin we dɛn want fɔ du, di mɔdel dɛn, di sayz dɛn, di kɔd dɛn fɔ di prɔdak, ɛn di matris fɔ kɔmpitishɔn;
- lɛbl ɛn instrɔkshɔn-fɔ-yuz tɛmplat dɛn wit kɔntrol rivishɔn ɛn langwej dɛn we dɛn kin yuz;
- matirial spɛsifikɛshɔn, diklareshɔn, ɛn rilevɛns bayolojikal-sefty pruf;
- risk-mɛnejmɛnt, verifyeshɔn, validɛshɔn, ɛn klinik ɔ pefɔmɛns dɔkyumentri usay i apɔynt;
- sterilayz, pak, transpɔt, shelf-layf, ɛn riprosɛs dɔkyumentri as i apɔynt;
- Diklɛreshɔn fɔ Kɔnfɔmiti, sɛtifiket, listin, kliarens, ɔ ɔtorizeshɔn rɛkɔd dɛn we dɛn nid fɔ di target makit.
Gri pan wan dɔkyumɛnt rispɔns tɛm fɔ di patikyula rɛjista pakej. Mekɔp kɔmplit, kɔnsistɛns, rivishɔn kɔntrol, ɛn ɔnaship—nɔto spid nɔmɔ.
3Traceability, UDI/EUDAMED Data, ɛn Chenj Kɔntrol
Wan traysabiliti sistɛm fɔ kɔnɛkt wan implant ɔ inschrumɛnt we dɔn dɔn to raw matirial, prodakshɔn rɛkɔd, inspekshɔn, ɔtsɔs prɔses, lɛbl, pak, sterilayz usay i apɔynt, ɛn rilis. Test di sistem bay we yu pik wan lɔt ɛn aks fɔ mek dɛn tray fɔ go bifo ɛn bak.
Fɔ EU prodak dɛm, ɛgzamin Aktɔ, UDI/Divays, sɛtifiket, ɛn manifakta data insay di kɔntɛks fɔ mandatory EUDAMED modul dɛm. Fɔ ɔda makit dɛn, chɛk di rilevɛns UDI kyaria, di ɛjɛnshi we de gi, di database, ɛn di lokal lɛbl rikwaymɛnt dɛn. UDI rɛdi pas laser mak: di aydentifaya ɛn database rɛkɔd fɔ kɔrɛkt to kɔntrol divays masta data.
4Manufakchurin Kapabiliti ɛn Prɔses Validɛshɔn
Wan prɔdak katalog nɔ de pruv se di pɔsin we de gi yu di tin dɛn de kɔntrol di tin dɛn we yu nid fɔ du fɔ yu divays. Map di prɔdak we dɛn want fɔ mek tru mashin, fɔj, ɔt tritmɛnt, wɛldin, polish, pasivɛshɔn, kɔtin, klin, asɛmbli, pak, sterilayz, ɛn fayn inspekshɔn. No us opareshɔn dɛn de du insay os ɛn uswan dɛn de ɔtsɔs.
Rivyu di spɔlayt in yon orthopedic implant manufacturing capabilities , dɔn verify dɛn agens di ikwipmɛnt rɛkɛd, ɔpreshɔn kwalifayeshɔn, prɔses validɛshɔn, mentenɛns, kalibreshɔn, inspekshɔn we, nɔ-kɔnfɔmeshɔn handlin, ɛn aktual batch rɛkɛd.
Afta wan saplay pas di mandatory kwalifayeshɔn get, kɔmpia kot yuz a risk-adjusted ɔtpidik spɔlayt kɔst mɔdel pas yunit prays nɔmɔ.
5Lid Taym, Invɛntari, ɛn Lɔjistik Rilaybiliti
Riples brayt prɔmis wit difinishɔn dɛn we pɔsin kin mɛzhɔ. Aks fɔ nɔmal ɛn pik kapasiti, lida tɛm bay di prɔdak famili, ɔda-kɔnfɔmeshɔn tɛm, minim ɔda kwantiti, stok stetɔs, fɔkɔs rikwaymɛnt, fil ret ɔ OTIF kɔlkyulɛshɔn, dilɛy ɛskalayshɔn, ɛn rikavari plan.
Rijinal westɛm kin ridyus di tɛm fɔ ful-ɔp, bɔt chɛk di fasiliti adrɛs, di SKU dɛn we dɛn dɔn stok, di invɛntari ɔnaship, di ripɔt frɛkuɛns, ritɔn prɔses, envayrɔmɛnt kɔntrol, pak-intɛgriti kɔntrol, ɛn savis-lɛvel agrimɛnt. Rivyu XC Medico in we dɛn dɔn pablish ɔtpidik saplai-chen ɛn westɛm mɔdel as wan input, dɔn aks fɔ pruf fɔ di pefɔmɛns we dɛn jɔs dɔn du.
6OEM / ODM Ɛnjinia ɛn Sampul Validɛshɔn
Kastamayzeshɔn de frɔm prayvet-lɛbul pak to nyu implant ɔ inschrumɛnt. Brandin, sɛt kɔnfigyushɔn, dimɛnshɔnal modifyeshɔn, ɛn nyu-prɔdakt divɛlɔpmɛnt nid difrɛn lɛvul dɛn fɔ dizayn kɔntrol ɛn rigyuletɔri asɛsmɛnt.
Rivyu di wan we mek am in yon ɔtpidik OEM/ODM manufakchurin wokflɔ . Difayn kɔnfidɛnsi, dizayn ɔnaship, tul ɔnaship, dizayn input, risk manejmɛnt, drɔin, verifyeshɔn, validɛshɔn, dizayn transfa, chenj kɔntrol, ɛn rigyuletɔri rispɔnsibiliti bifo yu apruv divɛlɔpmɛnt.
Rɔn wan payɔt we dɛn kin kɔntrol. Di sampul plan fɔ tɔk bɔt drɔin rivishɔn, matirial, krichɔ dimɛnshɔn, fɛnshɔnal ɛn intafɛs tɛst, akseptans krayteria, sampul kwantiti, ɛn aw di sampul we dɛn dɔn gri fɔ bi di prodakshɔn masta. Ɔda gayd de insay di Inglish ɔtpidik OEM/ODM prokyumɛnt gayd.
7Instrumɛnt, Trenin, Kɔmplen, ɛn Pɔst-Maket Sɔpɔt
Wan ɔtpidik implant sistɛm kin fel fɔ wok we in inschrumɛnt dɛn nɔ kɔmplit, we nɔ kɔmpitabl, we dɔn pwɛl, we nɔ de, ɔ we dɛn nɔ rayt fayn. Evaluate trey konfigyushɔn, inschrumɛnt-to-implant kɔmpatibiliti, kɔnt shit, riprosɛsin instrɔkshɔn, inspekshɔn krayteria, riplesmɛnt pat, ripa rod, riplenishmɛnt, ɛn trenin matirial.
Di post-maket rispɔnsibiliti fɔ kɔba kɔmplen intake, advɛs-ivent ɛskalayshɔn, invɛstishɔn, rut-kɔz analisis, CAPA, tren ripɔt, fil akshɔn ɔ rikɔl sɔpɔt, warranty, ripa, ɛn kɔmyunikeshɔn tɛmlayn. Rivyu di spɔlayt in pablish afta-sɛl ɛn kɔmplen-sɔpɔt prɔses , dɔn difayn di rispɔnsibiliti dɛn na wan kwaliti ɔ sapɔt agrimɛnt we dɛn rayt.
100-Point Ɔtpidik Spɔlayt Skɔkad
Skɔ ɛni kategori frɔm 0 to 5 ɛn multiply wit in weit. Kip di pruf dɛn we dɛn dɔn rivyu nia ɛni mak. Mandatory get dɛn fɔ pas ivin we di tɔtal skɔ ay.
| Krayteria | Weyt | Kɔr pruf | Mandatory get? |
|---|---|---|---|
| 1. QMS, rigyuletɔri stetɔs, ɛn ɔdit rɛdi | 20% . | Ligal aydentiti, sayt dɛn, ISO 13485 skɔp, QMSR/MDR rɛdi, prodak ɔtorizeshɔn. | Yɛs |
| 2. Dokumɛnt we rɛdi fɔ rɛjista | 15% . | Kɔntrol dosya, prodak masta data, lɛbl, IFU, tɛst, diklareshɔn ɛn sɛtifiket. | Yɛs |
| 3. Traceability, UDI, ɛn chenj kɔntrol | 15% . | Lot tray, UDI/divays data, kɔmplen linkej, ritɛnshɔn, kɔstɔma notis. | Yɛs |
| 4. Manufakchurin ɛn prɔses validɛshɔn | 15% . | Prɔses flɔ, validɛshɔn, kalibreshɔn, inspekshɔn, spɔlayt ɛn nɔ-kɔnfɔmɛns kɔntrol. | Yes fɔ skɔp |
| 5. Dilivri, invɛntari, ɛn lɔjistik | 15% . | Lid tɛm, kapasiti, stok, OTIF, ɛskalayshɔn, transpɔt ɛn kɔntinyuiti ɛvidɛns. | Domɔt |
| 6. OEM injinɛri ɛn sampul validɛshɔn | 10% . | Disain rispɔnsibiliti, drɔin, risk, verifyeshɔn, sampul ɛn fɔs-lɔt ɛvidɛns. | Dipen pan di prɔjek |
| 7. Instrumɛnt ɛn sɔpɔt afta di makit | 10% . | Trey kɔntrol, kɔmpitibliti, trenin, kɔmplen, CAPA, ripa ɛn warranty. | Domɔt |
Evidɛns skɔring skel
| Skɔ | Evidɛns lɛvɛl | Intɛpriteshɔn |
|---|---|---|
| 0 | No pruf nɔ de | Dɛn nɔ de adrɛs di tin dɛn we dɛn nid. |
| 1 | Na wɔd klem nɔmɔ | Maketing ɔ sɛl stetmɛnt we nɔ gɛt ɛni kɔntrol sɔpɔt. |
| 2 | Pruf we nɔ kɔmplit | Dokumɛnt dɛn dɔn ol, dɛn nɔ kɔrɛkt, dɛn na jenɛrik, ɔ dɛn nɔ gɛt di ki skɔp. |
| 3 | Pruf we pɔsin kin gri wit | Di rɛkɔd dɛn we dɛn de kɔntrol naw de sho klia wan wetin dɛn nid. |
| 4 | Strɔng pruf | Rikɔd dɛn gɛt ɛgzampul dɛn we dɛn jɔs dɔn mek, di we aw pɔsin kin tray fɔ no, di mɛtrik dɛn, ɛn di wan dɛn we gɛt di wok fɔ du. |
| 5 | Pruf we dɛn dɔn chɛk fɔ no bɔt | Evidɛns na prodak-linked, ripit, indipɛndɛnt kɔnfɔm usay i pɔsibul, ɛn sɔpɔt bay ifektiv kɔntrol. |
Wan prɛktikal aprɔval lɔ kin mek ɔl di get dɛn we dɛn fɔ pas, nɔ gɛt ɛni impɔtant tin we dɛn nɔ sɔlv, wan sampul ɔ fɔs lɔt we dɛn kin akseptabl, ɛn wan weit skɔ we pas di trɛshɔld we di pɔsin we bay di tin dɔn disayd. Di threshold fɔ sho di divays risk ɛn biznɛs krichɔliti pas wan yunivasal nɔmba.
Otomatik Diskwalifikeshɔn ɔ Ɛskalayshɔn Rɛd Flag dɛn
Aw fɔ Aplay di sem Framwɔk to XC Medico
Di sem pruf-based skɔ kad fɔ aplay to ɛvri kandidet, inklud XC Medico. Di wan dɛn we de bay kin bigin wit di pɔblik risɔs dɛn we de dɔŋ ya, dɔn dɛn kin aks fɔ di prɔdak-, makit-, ɛn sayt-spɛsifi k dɔkyumentri fɔ mek dɛn chɛk am.
Rilat Supplier Evalueshɔn Gayd dɛn
- US-spɛsifi k ɔtpidik implant ɛn inschrumɛnt spɔlayt vetin
- Ɔtpidik OEM/ODM prokyumɛnt ɛn projɛkt planin
- Wetin mek fɔs-ɔda margin kin ayd totɛl spɔlayt kɔst
Kwɛstyɔn dɛn we Dɛn kin Aks Bɔku tɛm
Wetin chenj pan ɔtpidik spɔlayt ɛvalueshɔn insay 2026?
Di FDA QMSR bin bigin fɔ wok pan Fɛbwari 2, 2026 ɛn i inkɔrpɔret ISO 13485:2016 bay rɛfrɛns wit US-spɛsifi k rikwaymɛnt dɛn. Di fɔs 4 EUDAMED modul dɛn bin bi mandatory frɔm May 28, 2026. Spɔlay rivyu dɛn fɔ naw tɛst pruf fɔ implimɛnt, nɔto jɔs aks if wan kɔmni gɛt ISO ɔ CE dɔkyumɛnt dɛn.
Aw yu kin chɛk fɔ si if yu gɛt ISO 13485 sɛtifiket?
Chek di ligal ɔganayzeshɔn nem, di adrɛs fɔ di sayt we dɛn mek am, di skɔp, di sɛtifiket nɔmba, di bɔdi we de gi di sɛtifiket, di akrediteshɔn, di stetɔs we de naw, ɛn di tɛm we i fɔ dɔn. Kɔmpia dɛn ditil dɛn de wit di rial prɔdak, lɛbl, diklareshɔn, kot, ɛn di wok we dɛn fɔ du fɔ mek am.
FDA rɛjista min se dɛn dɔn gri fɔ yuz ɔtpidik divays?
Nɔ, FDA establishmɛnt rɛjista ɛn divays list nɔ min se di fasiliti ɔ divays dɔn gri, klia, ɔ alaw. Verifay di ekzak divays klasifikeshɔn ɛn aplikebul rigyuletɔri path.
Us dɔkyumɛnt dɛn pɔsin we de gi ɔtpidik implant fɔ gi?
Di pakej we dɛn nid dipen pan di prɔdak ɛn di makit, bɔt bɔku tɛm i kin gɛt kɔntrol prodak masta data, matirial, drɔin, lɛbl, IFU, risk ɛn tɛst ɛvidɛns, sterilayzeshɔn ɛn pak infɔmeshɔn usay i apɔynt, diklareshɔn, sɛtifiket, ɛn prodak-spɛsifi k ɔtorizeshɔn rɛkɔd.
Yu tink se dɛn nid fɔ du ɔdit fɔ di saplay dɛn we de na di sayt ɔltɛm?
Nɔ, di dip fɔ di ɔdit fɔ bi risk-based. Dokumɛnt rivyu, layv rimot ɔdit, sampul tɛst, ɛn tɔd-pati pruf kin du fɔ sɔm tin dɛn we yu bay. Nyu implant sistem, steril divays, krichɔl ɔtsɔs prɔses, ripit kwaliti ishu, ɔ stratejik OEM program kin jɔstify wan on-sayt ɔdit.
Aw dɛn fɔ gi di ɔtpidik spɔlayt dɛn mak?
Yuz prɛdifayn 0–5 ɛvidɛns skɔ ɛn weit krayteria. Kip di rigyuletɔri, ligal, traysabiliti, ɛn impɔtant kwaliti rikwaymɛnt dɛn as mandatory get so dat prayz ɔ delivri skɔ nɔ go ebul fɔ kɔmpɛns fɔ mis kɔmplians.
Aw ɔltɛm dɛn fɔ ri-evalyu wan ɔtpidik saplay we dɛn dɔn gri fɔ?
Set di intaval akɔdin to divays ɛn saplae risk. Monitɔr difrɛns, kɔmplen, CAPA, delivri, savis, rigyuletɔri ɛn sɛtifiket stetɔs, ɛn chenj dɛn ɔltɛm. Siriɔs prɔblɛm ɔ big chenj dɛn fɔ mek dɛn rivyu am bifo tɛm.
Dɔn
Wan difensibl ɔtpidik spɔlayt ɛvalueshɔn de tɔn makɛt klem dɛn to ɛvidɛns we pɔsin kin tray fɔ no. Insay 2026, dat inklud QMSR implimɛnt fɔ US-maket manifakta dɛn ɛn EUDAMED rɛdi fɔ aplikebul EU prodak dɛm, nia di established fawndeshɔnal dɛm fɔ prodak dɔkyumentri, traysabiliti, validet manufakchurin, rilibul saplai, kɔntrol divɛlɔpmɛnt, ɛn post-maket sɔpɔt. Yuz di sem skɔ kad fɔ ɛvri kandidet ɛn kɔntinyu fɔ mɛzhɔ di pefɔmɛns afta dɛn dɔn gri fɔ am.
Rifrɛns dɛn we gɛt pawa
- US FDA: Kwaliti Manejmɛnt Sistɛm Rɛgyuleshɔn (QMSR).
- US FDA: QMSR Kwɛshɔn dɛn we dɛn kin aks bɔku tɛm.
- US FDA: Rɛjista versus divays aprɔval, kliarens, ɔ ɔtorizeshɔn.
- Yuropian Kɔmishɔn: Fɔs 4 EUDAMED modul dɛn mandatory frɔm May 28, 2026.
- Intanɛshɔnal Ɔganayzeshɔn fɔ Stɛndadayzeshɔn: ISO 13485—Mɛdikal divays kwaliti mɛnejɛmɛnt sistem.
